Catalyst Wire Dossier Catalyst Wire Dossier

Deleobuvir (BI 207127)

deleobuvir · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deleobuvir (BI 207127), covering 2016-04-14 to 2016-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects. [Phase 1]

See pricing